InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Phillips T Danny. Director active across 1 company, notably Caris Life Sciences, Inc.. In total, 3 reports have been logged. History available since 11 September 2025. The latest transaction was disclosed on 14 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations